Howard Wolpert
Enriched profileClinical Professor, Section of Endocrinology, Diabetes, Nutrition & Weight Management · Boston University Chobanian & Avedisian School of Medicine
Howard Wolpert is Clinical Professor, Section of Endocrinology, Diabetes, Nutrition & Weight Management at Boston University Chobanian & Avedisian School of Medicine. OpenAlex indexes 105 publications with 6,489 citations (h-index 36); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Howard Wolpert, MB, BCH, is Clinical Professor, Section of Endocrinology, Diabetes, Nutrition & Weight Management at Boston University Chobanian & Avedisian School of Medicine / Boston Medical Center. The public record shows 105 publications with 6,489 citations (h-index 36), centered on Diabetes Management and Research, Diabetes and associated disorders, Hyperglycemia and glycemic control in critically ill and hospitalized patients. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 2 companies, 2 NIH-funded awards (1993–2026).
- Most recent indexed publication: 2023 · Journal of diabetes science and technology
- Top research focus: Diabetes Management and Research
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 62.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
Sponsor: Boston Medical Center
- The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
Sponsor: Jaeb Center for Health Research
- Insulin Bolus Required for High Fat Foods in Type 1 Diabetes
Sponsor: Joslin Diabetes Center
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20253 payments$10,125openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20241 payment
- Eli Lilly and CompanyProgram year20231 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%GLP-1 receptor agonist42.7%Trulicity57%Mounjaro43%Part D<11 patientsInsulin Analog34%Fiasp Flextouch34%Lantus Solostar34%Toujeo Solostar31%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 1993–2026 per NIH RePORTER. The latest:
- Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience
Boston Medical Center
FY2026$844,525R01DK138309 - Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience
Boston Medical Center
FY2025$854,975R01DK138309 - Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience
Boston Medical Center
FY2024$899,996R01DK138309
Congress activity
Updated 27 Aug 2026
9 congress contributions (2019–2024) across ADA per OpenAlex. The most recent:
- 1906-LB: Identification of Missed Mealtime Insulin in Type 1 Diabetes Using Connected Insulin Pens
ADA Scientific Sessions
ADA2024Presenting authorLate-breaking - 819-P: Impact of Meal Bolus Timing and Bedtime Snacking on Glycemic Control in Hospitalized Patients
ADA Scientific Sessions
ADA2023Co-authorPoster - 1005-P: A Multimodel Model Predictive Controller Can Improve Glucose Control in Children with Type 1 Diabetes (T1D)
ADA Scientific Sessions
ADA2022Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
Journal of diabetes science and technology
Article2023 - Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes.
Diabetes technology & therapeutics
Article2022
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/howard-wolpert-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Howard-Wolpert-12271111
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/Tidepool_org/status/695614818137542656
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Internal Medicine residency (1984-1987) and Endocrinology
Diabetes & Metabolism fellowship (1987-1989), Beth Israel Deaconess Medical Center
1989provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sharecare.com ↗ - MBBCh
University of the Witwatersrand
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗ - BSc
University of the Witwatersrand
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗ - Board certified
Endocrinology, Diabetes & Metabolism
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- Member
Endocrine Society/European Society of Endocrinology joint committee on CGM clinical practice guidelines; primary writer of recommendations for outpatient CGM use in adults
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →joslin.org ↗ - Member
Scientific Advisory Board, EU-funded academic/industry diabetes technology collaborative (one of two foreign members)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →joslin.org ↗
Awards & honors
honors on the public record- JDRF Performance Award
Dr. Wolpert's group achieved the best outcome data among the ten centers participating in a JDRF-sponsored insulin pump trial
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →joslin.org ↗
Secondary affiliations
appointments beyond the home institution- Former Senior Physician
Section of Adult Diabetes, and Director, Institute for Technology Translation, Joslin Diabetes Center (Harvard Medical School affiliate); ~30-year tenure, left circa 2018-2023
2023provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →joslin.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glooko.com ↗
- Advisory board / consulting relationships with Abbott Diabetes Care
BD, Bigfoot Biomedical, Insulet, Novo Nordisk (advisory), and Dexcom, Zealand (consulting)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetestechnology.org ↗
Media & interviews
press, podcasts and appearances- "Dr. Howard Wolpert: The Long Road Taken"
feature profile, DiaTribe
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diatribe.org ↗ - "Legendary Diabetes Doc Howard Wolpert Turns His Focus to..."
feature/interview, Healthline DiabetesMine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthline.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →joslin.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Tuhina Neogi, MD
Boston University Chobanian & Avedisian School of Medicine
Wilson Colucci, MD
Boston University Chobanian & Avedisian School of Medicine
William Boden, MD
Boston University Chobanian & Avedisian School of Medicine
Naomi Hamburg, MD
Boston University Chobanian & Avedisian School of Medicine